Home Other Building Blocks 15964-79-1
15964-79-1,MFCD00017206
Catalog No.:AA001R6U

15964-79-1 | Methyl homoveratrate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$15.00   $11.00
- +
10g
97%
in stock  
$26.00   $18.00
- +
25g
97%
in stock  
$55.00   $39.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA001R6U
Chemical Name:
Methyl homoveratrate
CAS Number:
15964-79-1
Molecular Formula:
C11H14O4
Molecular Weight:
210.2265
MDL Number:
MFCD00017206
SMILES:
COC(=O)Cc1ccc(c(c1)OC)OC
Properties
Computed Properties
 
Complexity:
205  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
4  
Rotatable Bond Count:
5  
XLogP3:
1.3  

Upstream Synthesis Route

[1]Tetrahedron,2013,vol.69,#42,p.8914-8920

[2]JournalofOrganicChemistry,1961,vol.26,p.1754-1758

[3]JournalofOrganicChemistry,1964,vol.29,p.2372-2378

[4]Phytochemistry(Elsevier),1987,vol.26,#5,p.1453-1458

[5]Synthesis,1999,#5,p.885-897

[6]Synthesis,2011,#18,p.2935-2940

[1]BioorganicandMedicinalChemistryLetters,1999,vol.9,#1,p.85-90

[2]Tetrahedron,2007,vol.63,#46,p.11377-11385

[3]Tetrahedron,2013,vol.69,#42,p.8914-8920

[4]Patent:US2012/214837,2012,A1,.Locationinpatent:Page/Pagecolumn23-24

[5]JournalofOrganicChemistry,2003,vol.68,#3,p.1165-1167

[6]JournalofOrganicChemistry,2009,vol.74,#9,p.3491-3499

[7]JournalofOrganicChemistry,1990,vol.55,#4,p.1261-1266

[8]Patent:CN105153105,2018,B,.Locationinpatent:Paragraph0068-0070

[9]JournalofOrganicChemistry,2016,vol.81,#15,p.6808-6815

[10]BioorganicandMedicinalChemistryLetters,2009,vol.19,#19,p.5594-5598

[11]JournalofMedicinalChemistry,2012,vol.55,#24,p.10863-10884

[12]SyntheticCommunications,2014,vol.44,#16,p.2386-2392

[13]JournaloftheAmericanChemicalSociety,2015,vol.137,#32,p.10246-10253

[14]TetrahedronLetters,1996,vol.37,#8,p.1233-1236

[15]ArchivderPharmazie(Weinheim,Germany),1933,vol.271,p.431,435

[16]Tetrahedron,1992,vol.48,#38,p.8285-8294

[17]Patent:US2007/287708,2007,A1,.Locationinpatent:Page/Pagecolumn28

[18]Patent:US2007/287738,2007,A1,.Locationinpatent:Page/Pagecolumn17

[19]SyntheticCommunications,2008,vol.38,#21,p.3662-3671

[20]Synthesis,2011,#18,p.2935-2940

[21]BioorganicandMedicinalChemistryLetters,2011,vol.21,#21,p.6567-6572

[22]Patent:WO2012/145234,2012,A2,.Locationinpatent:Page/Pagecolumn31-32

[23]JournaloftheAmericanChemicalSociety,2013,vol.135,#18,p.6774-6777

[24]Patent:EP2871187,2015,A1,.Locationinpatent:Paragraph0063-0064

[25]Patent:US2015/183797,2015,A1,.Locationinpatent:Paragraph0160-0162

[26]Chemistry-AEuropeanJournal,2015,vol.21,#36,p.12601-12605

[27]TetrahedronLetters,2016,vol.57,#8,p.849-851

[1]Patent:US6630597,2003,B1,

[1]Patent:US2009/41669,2009,A1,

[1]ChemicalCommunications,2009,#13,p.1739-1741

Downstream Synthesis Route

[1]BioorganicandMedicinalChemistryLetters,1999,vol.9,p.85-90

[2]Tetrahedron,2007,vol.63,p.11377-11385

[3]Tetrahedron,2013,vol.69,p.8914-8920

[4]Patent:US2012/214837,2012,A1.Locationinpatent:Page/Pagecolumn23-24

[5]JournalofOrganicChemistry,2003,vol.68,p.1165-1167

[6]JournalofOrganicChemistry,2009,vol.74,p.3491-3499

[7]JournalofOrganicChemistry,1990,vol.55,p.1261-1266

[8]Patent:CN105153105,2018,B.Locationinpatent:Paragraph0068-0070

[9]JournalofOrganicChemistry,2016,vol.81,p.6808-6815

[10]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.5594-5598

[11]JournalofMedicinalChemistry,2012,vol.55,p.10863-10884

[12]SyntheticCommunications,2014,vol.44,p.2386-2392

[13]JournaloftheAmericanChemicalSociety,2015,vol.137,p.10246-10253

[14]TetrahedronLetters,1996,vol.37,p.1233-1236

[15]ArchivderPharmazie,1933,vol.271,p.431,435

[16]Tetrahedron,1992,vol.48,p.8285-8294

[17]Patent:US2007/287708,2007,A1.Locationinpatent:Page/Pagecolumn28

[18]Patent:US2007/287738,2007,A1.Locationinpatent:Page/Pagecolumn17

[19]SyntheticCommunications,2008,vol.38,p.3662-3671

[20]Synthesis,2011,p.2935-2940

[21]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.6567-6572

[22]Patent:WO2012/145234,2012,A2.Locationinpatent:Page/Pagecolumn31-32

[23]JournaloftheAmericanChemicalSociety,2013,vol.135,p.6774-6777

[24]Patent:EP2871187,2015,A1.Locationinpatent:Paragraph0063-0064

[25]Patent:US2015/183797,2015,A1.Locationinpatent:Paragraph0160-0162

[26]Chemistry-AEuropeanJournal,2015,vol.21,p.12601-12605

[27]TetrahedronLetters,2016,vol.57,p.849-851

[1]JournaloftheChemicalSociety.PerkintransactionsI,1991,p.169-173

[2]JournaloftheChemicalSociety,1952,p.1763,1766

[3]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.6567-6572

[1]Tetrahedron,2013,vol.69,p.8914-8920

[2]JournalofOrganicChemistry,1961,vol.26,p.1754-1758

[3]JournalofOrganicChemistry,1964,vol.29,p.2372-2378

[4]Phytochemistry,1987,vol.26,p.1453-1458

[5]Synthesis,1999,p.885-897

[6]Synthesis,2011,p.2935-2940

[1]JournaloftheChemicalSociety.Chemicalcommunications,1989,p.1162-1164

[2]OrganicLetters,2014,vol.16,p.6068-6071

[3]AngewandteChemie-InternationalEdition,2014,vol.53,p.10737-10741

[4]JournalofOrganicChemistry,2009,vol.74,p.3491-3499

[5]JournalofOrganicChemistry,1990,vol.55,p.1261-1266

[1]JournalofMedicinalChemistry,1988,vol.31,p.1363-1368

[2]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.5594-5598

[3]Patent:US2012/214837,2012,A1.Locationinpatent:Page/Pagecolumn24

Literature

Title: Wu WN, et al. Biotransformation of an antihypertensive arylalkylamine analogue in the rat. Xenobiotica. 1998 Oct;28(10):957-72.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:15964-79-1 Molecular Formula|15964-79-1 MDL|15964-79-1 SMILES|15964-79-1 Methyl homoveratrate